Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • anglabat1
    Junior Member
    • Mar 2017
    • 1

    #1

    Options for poorly pooled samples

    Hi,

    I have a project where we are reporting on differentially expressed genes between infected samples and negative controls. After sending out several successful test lanes, we submitted all of our remaining libraries to our core for RNA-seq last week. We sequenced on a Hiseq 4000. The results returned number of reads assigned to samples is askew for most lanes. As an example

    Samples read #
    Lane 1
    sample 1 118,369,316
    sample 2 127,860,068
    sample 3 33,369,611
    sample 4 74,631,001
    sample 5 892,059
    sample 6 52,788,867

    and

    Lane 2 (most lanes look like this)
    sample 1 106,314,515
    sample 2 36,354,411
    sample 3 28,392,645
    sample 4 74,239,452
    sample 5 80,632,554
    sample 6 83,282,609

    In most cases, I have one or two samples per lane that have ~25 million reads, while another one or two will have ~100 million.

    All indices are accounted for and there is no indication of significant adaptors or short fragments and they have the same profiles of base composition, GC content. Despite working off of high sensitivity qubit readings (the core discouraged me from doing qpcr on the individual libraries - a mistake I'm not going to repeat), the bioanalyzer fragment size, and having three people crosscheck concentration calculations as well as oversee the actual pooling, the problem appears to be bad equimolar pooling. The uneven pooling is happening between negative controls and their infected sample mate. The samples causing the most trouble are low concentration samples.

    These are very hard won samples - taken from small animals, RNA extracted from few cells etc.. Gathered over the course of a full year. The deal is, for many of the samples we have no more library to sequence a second time. My budget is also depleted. If the project is to continue the only option I have is to make use of these specific sequences. I'm just not sure what to do. If there is nothing to be done, after investing a year in time and close to 100K in resources, the project dies right here.

    So I'm writing to ask two things 1) are there post-sequencing options I can pursue to make this data useful? Can I, for example, randomly remove reads from over-sequenced samples so that they have a similar count to the lower-sequenced samples. 2) we proceeded to this point very carefully and still, this uneven pooling occurred. Is there something I'm missing here? Is there anything else I should be doing in advance of pooling for sequencing?

    and a third thing. If anyone has a line on a core that will pool for me, please PM a recommendation to me. I'm not inclined to use our facilities again.
  • HeinKey
    Member
    • May 2009
    • 21

    #2
    Hi anglabat1,

    I think it is save to randomly remove reads from the over sequenced samples. They are randomly devided over the flow cell, and ordered on pixel position. So taking the same first number of reads for each sample will do.
    We prefer to qPCR before pooling since you will relatively quantify within that qPCr experiment and are able to adjust to similar amplifiable concentrations. QuBit is OK is library prep went well. If adapter ligation was not optimal you will miss that on the QuBit, but will correct for that after qPCR.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM
    • SEQadmin2
      New Genomics Technologies Take Aim at Long-Standing Limits
      by SEQadmin2


      Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

      We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
      ...
      09-28-2026, 10:25 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 10-22-2026, 11:13 AM
    0 responses
    43 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-22-2026, 10:48 AM
    0 responses
    33 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-15-2026, 10:52 AM
    0 responses
    44 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-14-2026, 05:39 AM
    0 responses
    45 views
    0 reactions
    Last Post SEQadmin2  
    Working...